Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON
Author(s) -
Patrick H. Pun,
Susan T. Crowley
Publication year - 2020
Publication title -
kidney360
Language(s) - English
Resource type - Journals
ISSN - 2641-7650
DOI - 10.34067/kid.0005572020
Subject(s) - nephrogenic systemic fibrosis , medicine , gadolinium , kidney disease , magnetic resonance imaging , disease , adverse effect , food and drug administration , radiology , pharmacology , chemistry , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom